GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2019-12

AUTHORS

Geraldine Vidhya Vijay, Na Zhao, Petra Den Hollander, Mike J. Toneff, Robiya Joseph, Mika Pietila, Joseph H. Taube, Tapasree R. Sarkar, Esmeralda Ramirez-Pena, Steven J. Werden, Maryam Shariati, Ruli Gao, Mary Sobieski, Clifford C. Stephan, Nathalie Sphyris, Noayuki Miura, Peter Davies, Jeffrey T. Chang, Rama Soundararajan, Jeffrey M. Rosen, Sendurai A. Mani

ABSTRACT

BACKGROUND: Triple-negative breast cancers (TNBCs), which lack receptors for estrogen, progesterone, and amplification of epidermal growth factor receptor 2, are highly aggressive. Consequently, patients diagnosed with TNBCs have reduced overall and disease-free survival rates compared to patients with other subtypes of breast cancer. TNBCs are characterized by the presence of cancer cells with mesenchymal properties, indicating that the epithelial to mesenchymal transition (EMT) plays a major role in the progression of this disease. The EMT program has also been implicated in chemoresistance, tumor recurrence, and induction of cancer stem cell (CSC) properties. Currently, there are no targeted therapies for TNBC, and hence, it is critical to identify the novel targets to treat TNBC. METHODS: A library of compounds was screened for their ability to inhibit EMT in cells with mesenchymal phenotype as assessed using the previously described Z-cad reporters. Of the several drugs tested, GSK3β inhibitors were identified as EMT inhibitors. The effects of GSK3β inhibitors on the properties of TNBC cells with a mesenchymal phenotype were assessed using qRT-PCR, flow cytometry, western blot, mammosphere, and migration and cell viability assays. Publicly available datasets also were analyzed to examine if the expression of GSK3β correlates with the overall survival of breast cancer patients. RESULTS: We identified a GSK3β inhibitor, BIO, in a drug screen as one of the most potent inhibitors of EMT. BIO and two other GSK3β inhibitors, TWS119 and LiCl, also decreased the expression of mesenchymal markers in several different cell lines with a mesenchymal phenotype. Further, inhibition of GSK3β reduced EMT-related migratory properties of cells with mesenchymal properties. To determine if GSK3β inhibitors target mesenchymal-like cells by affecting the CSC population, we employed mammosphere assays and profiled the stem cell-related cell surface marker CD44+/24- in cells after exposure to GSK3β inhibitors. We found that GSK3β inhibitors indeed decreased the CSC properties of cell types with mesenchymal properties. We treated cells with epithelial and mesenchymal properties with GSK3β inhibitors and found that GSK3β inhibitors selectively kill cells with mesenchymal attributes while sparing cells with epithelial properties. We analyzed patient data to identify genes predictive of poor clinical outcome that could serve as novel therapeutic targets for TNBC. The Wnt signaling pathway is critical to EMT, but among the various factors known to be involved in Wnt signaling, only the higher expression of GSK3β correlated with poorer overall patient survival. CONCLUSIONS: Taken together, our data demonstrate that GSK3β is a potential target for TNBCs and suggest that GSK3β inhibitors could serve as selective inhibitors of EMT and CSC properties for the treatment of a subset of aggressive TNBC. GSK3β inhibitors should be tested for use in combination with standard-of-care drugs in preclinical TNBC models. More... »

PAGES

37

References to SciGraph publications

  • 2015-08. Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update in NATURE REVIEWS CLINICAL ONCOLOGY
  • 2012-11. GSK3β and cyclin D1 expression predicts outcome in early breast cancer patients in BREAST CANCER RESEARCH AND TREATMENT
  • 2015-11. Targeting self-renewal pathways in cancer stem cells: clinical implications for cancer therapy in ONCOGENESIS
  • 2015-12. Blockade of Wnt/β-catenin signaling suppresses breast cancer metastasis by inhibiting CSC-like phenotype in SCIENTIFIC REPORTS
  • 2012-06. Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat in BREAST CANCER RESEARCH
  • 2014-06. Breast cancer intra-tumor heterogeneity in BREAST CANCER RESEARCH
  • 2016-11. Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease in NATURE REVIEWS CLINICAL ONCOLOGY
  • 2014-09. Targeting cancer stem cells to suppress acquired chemotherapy resistance in ONCOGENE
  • 2009-01. Roles of TGF-β family signaling in stem cell renewal and differentiation in CELL RESEARCH
  • 2012-12. Clinical and biologic features of triple-negative breast cancers in a large cohort of patients with long-term follow-up in BREAST CANCER RESEARCH AND TREATMENT
  • 2017-04. Wnt signaling in triple-negative breast cancer in ONCOGENESIS
  • 2013-12. Mechanisms of chemoresistance in cancer stem cells in CLINICAL AND TRANSLATIONAL MEDICINE
  • 2015-06. GD3 synthase regulates epithelial–mesenchymal transition and metastasis in breast cancer in ONCOGENE
  • 2017-04-11. EMT, CSCs, and drug resistance: the mechanistic link and clinical implications in NATURE REVIEWS CLINICAL ONCOLOGY
  • 2012-09-23. Comprehensive molecular portraits of human breast tumours in NATURE
  • 2007-04. Glycogen Synthase Kinase-3 (GSK3): Inflammation, Diseases, and Therapeutics in NEUROCHEMICAL RESEARCH
  • 2004-06. GSK3 inhibitors: development and therapeutic potential in NATURE REVIEWS DRUG DISCOVERY
  • 2016-12. The Z-cad dual fluorescent sensor detects dynamic changes between the epithelial and mesenchymal cellular states in BMC BIOLOGY
  • 2014-03. Molecular mechanisms of epithelial–mesenchymal transition in NATURE REVIEWS MOLECULAR CELL BIOLOGY
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1186/s13058-019-1125-0

    DOI

    http://dx.doi.org/10.1186/s13058-019-1125-0

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1112606607

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/30845991


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Oncology and Carcinogenesis", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "The University of Texas MD Anderson Cancer Center", 
              "id": "https://www.grid.ac/institutes/grid.240145.6", 
              "name": [
                "Department of Translational Molecular Pathology, UT MD Anderson Cancer Center, Houston, TX, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Vijay", 
            "givenName": "Geraldine Vidhya", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Baylor College of Medicine", 
              "id": "https://www.grid.ac/institutes/grid.39382.33", 
              "name": [
                "Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Zhao", 
            "givenName": "Na", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "The University of Texas MD Anderson Cancer Center", 
              "id": "https://www.grid.ac/institutes/grid.240145.6", 
              "name": [
                "Department of Translational Molecular Pathology, UT MD Anderson Cancer Center, Houston, TX, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Den Hollander", 
            "givenName": "Petra", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Baylor College of Medicine", 
              "id": "https://www.grid.ac/institutes/grid.39382.33", 
              "name": [
                "Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Toneff", 
            "givenName": "Mike J.", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "The University of Texas MD Anderson Cancer Center", 
              "id": "https://www.grid.ac/institutes/grid.240145.6", 
              "name": [
                "Department of Translational Molecular Pathology, UT MD Anderson Cancer Center, Houston, TX, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Joseph", 
            "givenName": "Robiya", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "University of Turku", 
              "id": "https://www.grid.ac/institutes/grid.1374.1", 
              "name": [
                "Turku Centre for Biotechnology, University of Turku, Tykist\u00f6katu 6, 20520, Turku, Finland"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Pietila", 
            "givenName": "Mika", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Baylor University", 
              "id": "https://www.grid.ac/institutes/grid.252890.4", 
              "name": [
                "Department of Biology, Baylor University, Waco, TX, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Taube", 
            "givenName": "Joseph H.", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Texas A&M University", 
              "id": "https://www.grid.ac/institutes/grid.264756.4", 
              "name": [
                "Center for Statistical Bioinformatics, Texas A&M University, College Station, TX, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Sarkar", 
            "givenName": "Tapasree R.", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "The University of Texas MD Anderson Cancer Center", 
              "id": "https://www.grid.ac/institutes/grid.240145.6", 
              "name": [
                "Department of Translational Molecular Pathology, UT MD Anderson Cancer Center, Houston, TX, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Ramirez-Pena", 
            "givenName": "Esmeralda", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "The University of Texas MD Anderson Cancer Center", 
              "id": "https://www.grid.ac/institutes/grid.240145.6", 
              "name": [
                "Department of Translational Molecular Pathology, UT MD Anderson Cancer Center, Houston, TX, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Werden", 
            "givenName": "Steven J.", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "The University of Texas MD Anderson Cancer Center", 
              "id": "https://www.grid.ac/institutes/grid.240145.6", 
              "name": [
                "Department of Translational Molecular Pathology, UT MD Anderson Cancer Center, Houston, TX, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Shariati", 
            "givenName": "Maryam", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "The University of Texas MD Anderson Cancer Center", 
              "id": "https://www.grid.ac/institutes/grid.240145.6", 
              "name": [
                "Department of Genetics, The University of Texas MD Anderson Cancer Center, 77030, Houston, TX, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Gao", 
            "givenName": "Ruli", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Texas A&M Health Science Center", 
              "id": "https://www.grid.ac/institutes/grid.418866.5", 
              "name": [
                "Center for Translational Cancer Research, Texas A&M Health Science Center, Institute of Biosciences and Technology, Houston, TX, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Sobieski", 
            "givenName": "Mary", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Texas A&M Health Science Center", 
              "id": "https://www.grid.ac/institutes/grid.418866.5", 
              "name": [
                "Center for Translational Cancer Research, Texas A&M Health Science Center, Institute of Biosciences and Technology, Houston, TX, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Stephan", 
            "givenName": "Clifford C.", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "The University of Texas MD Anderson Cancer Center", 
              "id": "https://www.grid.ac/institutes/grid.240145.6", 
              "name": [
                "Department of Translational Molecular Pathology, UT MD Anderson Cancer Center, Houston, TX, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Sphyris", 
            "givenName": "Nathalie", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Hamamatsu University", 
              "id": "https://www.grid.ac/institutes/grid.411951.9", 
              "name": [
                "Department of Biochemistry, Hamamatsu University School of Medicine, Hamamatsu, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Miura", 
            "givenName": "Noayuki", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Texas A&M Health Science Center", 
              "id": "https://www.grid.ac/institutes/grid.418866.5", 
              "name": [
                "Center for Translational Cancer Research, Texas A&M Health Science Center, Institute of Biosciences and Technology, Houston, TX, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Davies", 
            "givenName": "Peter", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "The University of Texas Health Science Center at Houston", 
              "id": "https://www.grid.ac/institutes/grid.267308.8", 
              "name": [
                "Department of Integrative Biology and Pharmacology, School of Medicine, School of Biomedical Informatics, UT Health Sciences Center at Houston, Houston, TX, USA", 
                "Center for Clinical and Translational Sciences, The University of Texas Health Science Center at Houston, Houston, TX, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Chang", 
            "givenName": "Jeffrey T.", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "The University of Texas MD Anderson Cancer Center", 
              "id": "https://www.grid.ac/institutes/grid.240145.6", 
              "name": [
                "Department of Translational Molecular Pathology, UT MD Anderson Cancer Center, Houston, TX, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Soundararajan", 
            "givenName": "Rama", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Baylor College of Medicine", 
              "id": "https://www.grid.ac/institutes/grid.39382.33", 
              "name": [
                "Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Rosen", 
            "givenName": "Jeffrey M.", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "The University of Texas MD Anderson Cancer Center", 
              "id": "https://www.grid.ac/institutes/grid.240145.6", 
              "name": [
                "Department of Translational Molecular Pathology, UT MD Anderson Cancer Center, Houston, TX, USA", 
                "Metastasis Research Center, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Mani", 
            "givenName": "Sendurai A.", 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "https://doi.org/10.1016/s1097-2765(01)00253-2", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1000142222"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.ccr.2006.01.013", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1000216868"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrm3758", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1000491787", 
              "https://doi.org/10.1038/nrm3758"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/onc.2013.411", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1001049720", 
              "https://doi.org/10.1038/onc.2013.411"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/onc.2013.411", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1001049720", 
              "https://doi.org/10.1038/onc.2013.411"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.chembiol.2003.11.010", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1001271766"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2147/ott.s91863", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1001513144"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1158/1535-7163.mct-14-0778", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1002334728"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1158/1078-0432.ccr-14-2820", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1002537319"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1158/1078-0432.ccr-14-2820", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1002537319"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1073/pnas.1004900107", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1003168562"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1073/pnas.0703900104", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1007846183"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.3390/jcm5020013", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1009522152"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1111/bdi.12361", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1010874330"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.pharmthera.2014.11.016", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1011065299"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrclinonc.2016.66", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1011587927", 
              "https://doi.org/10.1038/nrclinonc.2016.66"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/s12915-016-0269-y", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1015110461", 
              "https://doi.org/10.1186/s12915-016-0269-y"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/s12915-016-0269-y", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1015110461", 
              "https://doi.org/10.1186/s12915-016-0269-y"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1158/0008-5472.can-06-3895", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1015133922"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/s1476-5586(04)80047-2", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1019351767"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1158/0008-5472.can-09-3360", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1019637270"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1111/j.1440-169x.2009.01141.x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1023177784"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1111/j.1440-169x.2009.01141.x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1023177784"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nature11412", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1024942368", 
              "https://doi.org/10.1038/nature11412"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1093/abbs/gmv130", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1026347802"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1172/jci39104", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1026879393"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1172/jci39104", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1026879393"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1006/bbrc.2000.4169", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1026928841"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.3390/cancers8070060", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1028941023"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/2001-1326-2-3", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1029680491", 
              "https://doi.org/10.1186/2001-1326-2-3"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.3390/cancers5041545", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1030381029"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/cr.2008.323", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1031139620", 
              "https://doi.org/10.1038/cr.2008.323"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/srep12465", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1031306920", 
              "https://doi.org/10.1038/srep12465"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.18632/oncotarget.10337", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1034068484"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1172/jci45014", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1037799511"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.tibs.2009.10.002", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1038223348"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.18632/oncotarget.2037", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1039354139"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1158/0008-5472.can-12-2962", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1041219104"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.cell.2006.10.018", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1041684641"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.cell.2008.03.027", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1042567148"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/bcr3658", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1043424385", 
              "https://doi.org/10.1186/bcr3658"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/onc.2014.245", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1043471529", 
              "https://doi.org/10.1038/onc.2014.245"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.cell.2010.11.034", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1043690423"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1177/2045125312471963", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1043851180"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1177/2045125312471963", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1043851180"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s11064-006-9128-5", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1043905982", 
              "https://doi.org/10.1007/s11064-006-9128-5"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s10549-012-2229-8", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1044204802", 
              "https://doi.org/10.1007/s10549-012-2229-8"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1242/dev.066209", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1046726359"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/bcr3192", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1046823214", 
              "https://doi.org/10.1186/bcr3192"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.18632/oncotarget.11875", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1048063128"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.ccr.2004.05.015", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1048372678"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.3109/03008207.2015.1066780", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1049695200"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrclinonc.2015.61", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1050085746", 
              "https://doi.org/10.1038/nrclinonc.2015.61"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s10549-012-2315-y", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1050772229", 
              "https://doi.org/10.1007/s10549-012-2315-y"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.3389/fnmol.2012.00014", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1051112334"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrd1415", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1051744913", 
              "https://doi.org/10.1038/nrd1415"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrd1415", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1051744913", 
              "https://doi.org/10.1038/nrd1415"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1073/pnas.0732087100", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1052919657"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/0471141755.ph1425s61", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1053049974"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/oncsis.2015.35", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1053596349", 
              "https://doi.org/10.1038/oncsis.2015.35"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1021/cn5000309", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1053802760"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1192/bjp.bp.116.181362", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1064192192"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.4161/19336918.2014.972761", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1072288597"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1155/2017/2925869", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1084229182"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/oncsis.2017.14", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1084508969", 
              "https://doi.org/10.1038/oncsis.2017.14"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrclinonc.2017.44", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1084764660", 
              "https://doi.org/10.1038/nrclinonc.2017.44"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2019-12", 
        "datePublishedReg": "2019-12-01", 
        "description": "BACKGROUND: Triple-negative breast cancers (TNBCs), which lack receptors for estrogen, progesterone, and amplification of epidermal growth factor receptor 2, are highly aggressive. Consequently, patients diagnosed with TNBCs have reduced overall and disease-free survival rates compared to patients with other subtypes of breast cancer. TNBCs are characterized by the presence of cancer cells with mesenchymal properties, indicating that the epithelial to mesenchymal transition (EMT) plays a major role in the progression of this disease. The EMT program has also been implicated in chemoresistance, tumor recurrence, and induction of cancer stem cell (CSC) properties. Currently, there are no targeted therapies for TNBC, and hence, it is critical to identify the novel targets to treat TNBC.\nMETHODS: A library of compounds was screened for their ability to inhibit EMT in cells with mesenchymal phenotype as assessed using the previously described Z-cad reporters. Of the several drugs tested, GSK3\u03b2 inhibitors were identified as EMT inhibitors. The effects of GSK3\u03b2 inhibitors on the properties of TNBC cells with a mesenchymal phenotype were assessed using qRT-PCR, flow cytometry, western blot, mammosphere, and migration and cell viability assays. Publicly available datasets also were analyzed to examine if the expression of GSK3\u03b2 correlates with the overall survival of breast cancer patients.\nRESULTS: We identified a GSK3\u03b2 inhibitor, BIO, in a drug screen as one of the most potent inhibitors of EMT. BIO and two other GSK3\u03b2 inhibitors, TWS119 and LiCl, also decreased the expression of mesenchymal markers in several different cell lines with a mesenchymal phenotype. Further, inhibition of GSK3\u03b2 reduced EMT-related migratory properties of cells with mesenchymal properties. To determine if GSK3\u03b2 inhibitors target mesenchymal-like cells by affecting the CSC population, we employed mammosphere assays and profiled the stem cell-related cell surface marker CD44+/24- in cells after exposure to GSK3\u03b2 inhibitors. We found that GSK3\u03b2 inhibitors indeed decreased the CSC properties of cell types with mesenchymal properties. We treated cells with epithelial and mesenchymal properties with GSK3\u03b2 inhibitors and found that GSK3\u03b2 inhibitors selectively kill cells with mesenchymal attributes while sparing cells with epithelial properties. We analyzed patient data to identify genes predictive of poor clinical outcome that could serve as novel therapeutic targets for TNBC. The Wnt signaling pathway is critical to EMT, but among the various factors known to be involved in Wnt signaling, only the higher expression of GSK3\u03b2 correlated with poorer overall patient survival.\nCONCLUSIONS: Taken together, our data demonstrate that GSK3\u03b2 is a potential target for TNBCs and suggest that GSK3\u03b2 inhibitors could serve as selective inhibitors of EMT and CSC properties for the treatment of a subset of aggressive TNBC. GSK3\u03b2 inhibitors should be tested for use in combination with standard-of-care drugs in preclinical TNBC models.", 
        "genre": "research_article", 
        "id": "sg:pub.10.1186/s13058-019-1125-0", 
        "inLanguage": [
          "en"
        ], 
        "isAccessibleForFree": true, 
        "isFundedItemOf": [
          {
            "id": "sg:grant.5126625", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.7051777", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.2481213", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.7051495", 
            "type": "MonetaryGrant"
          }
        ], 
        "isPartOf": [
          {
            "id": "sg:journal.1022375", 
            "issn": [
              "1465-5411", 
              "1465-542X"
            ], 
            "name": "Breast Cancer Research", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "1", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "21"
          }
        ], 
        "name": "GSK3\u03b2 regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer", 
        "pagination": "37", 
        "productId": [
          {
            "name": "readcube_id", 
            "type": "PropertyValue", 
            "value": [
              "3fb8ac3db2bd9e381a085b8b5ae3fd9559b8b751acdb5503513ebcc8a70a1df1"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "30845991"
            ]
          }, 
          {
            "name": "nlm_unique_id", 
            "type": "PropertyValue", 
            "value": [
              "100927353"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1186/s13058-019-1125-0"
            ]
          }, 
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1112606607"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1186/s13058-019-1125-0", 
          "https://app.dimensions.ai/details/publication/pub.1112606607"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2019-04-11T13:18", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000368_0000000368/records_78947_00000001.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://link.springer.com/10.1186%2Fs13058-019-1125-0"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s13058-019-1125-0'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s13058-019-1125-0'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s13058-019-1125-0'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s13058-019-1125-0'


     

    This table displays all metadata directly associated to this object as RDF triples.

    416 TRIPLES      21 PREDICATES      88 URIs      21 LITERALS      9 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1186/s13058-019-1125-0 schema:about anzsrc-for:11
    2 anzsrc-for:1112
    3 schema:author N04dc533220794444b509dda41a427ed6
    4 schema:citation sg:pub.10.1007/s10549-012-2229-8
    5 sg:pub.10.1007/s10549-012-2315-y
    6 sg:pub.10.1007/s11064-006-9128-5
    7 sg:pub.10.1038/cr.2008.323
    8 sg:pub.10.1038/nature11412
    9 sg:pub.10.1038/nrclinonc.2015.61
    10 sg:pub.10.1038/nrclinonc.2016.66
    11 sg:pub.10.1038/nrclinonc.2017.44
    12 sg:pub.10.1038/nrd1415
    13 sg:pub.10.1038/nrm3758
    14 sg:pub.10.1038/onc.2013.411
    15 sg:pub.10.1038/onc.2014.245
    16 sg:pub.10.1038/oncsis.2015.35
    17 sg:pub.10.1038/oncsis.2017.14
    18 sg:pub.10.1038/srep12465
    19 sg:pub.10.1186/2001-1326-2-3
    20 sg:pub.10.1186/bcr3192
    21 sg:pub.10.1186/bcr3658
    22 sg:pub.10.1186/s12915-016-0269-y
    23 https://doi.org/10.1002/0471141755.ph1425s61
    24 https://doi.org/10.1006/bbrc.2000.4169
    25 https://doi.org/10.1016/j.ccr.2004.05.015
    26 https://doi.org/10.1016/j.ccr.2006.01.013
    27 https://doi.org/10.1016/j.cell.2006.10.018
    28 https://doi.org/10.1016/j.cell.2008.03.027
    29 https://doi.org/10.1016/j.cell.2010.11.034
    30 https://doi.org/10.1016/j.chembiol.2003.11.010
    31 https://doi.org/10.1016/j.pharmthera.2014.11.016
    32 https://doi.org/10.1016/j.tibs.2009.10.002
    33 https://doi.org/10.1016/s1097-2765(01)00253-2
    34 https://doi.org/10.1016/s1476-5586(04)80047-2
    35 https://doi.org/10.1021/cn5000309
    36 https://doi.org/10.1073/pnas.0703900104
    37 https://doi.org/10.1073/pnas.0732087100
    38 https://doi.org/10.1073/pnas.1004900107
    39 https://doi.org/10.1093/abbs/gmv130
    40 https://doi.org/10.1111/bdi.12361
    41 https://doi.org/10.1111/j.1440-169x.2009.01141.x
    42 https://doi.org/10.1155/2017/2925869
    43 https://doi.org/10.1158/0008-5472.can-06-3895
    44 https://doi.org/10.1158/0008-5472.can-09-3360
    45 https://doi.org/10.1158/0008-5472.can-12-2962
    46 https://doi.org/10.1158/1078-0432.ccr-14-2820
    47 https://doi.org/10.1158/1535-7163.mct-14-0778
    48 https://doi.org/10.1172/jci39104
    49 https://doi.org/10.1172/jci45014
    50 https://doi.org/10.1177/2045125312471963
    51 https://doi.org/10.1192/bjp.bp.116.181362
    52 https://doi.org/10.1242/dev.066209
    53 https://doi.org/10.18632/oncotarget.10337
    54 https://doi.org/10.18632/oncotarget.11875
    55 https://doi.org/10.18632/oncotarget.2037
    56 https://doi.org/10.2147/ott.s91863
    57 https://doi.org/10.3109/03008207.2015.1066780
    58 https://doi.org/10.3389/fnmol.2012.00014
    59 https://doi.org/10.3390/cancers5041545
    60 https://doi.org/10.3390/cancers8070060
    61 https://doi.org/10.3390/jcm5020013
    62 https://doi.org/10.4161/19336918.2014.972761
    63 schema:datePublished 2019-12
    64 schema:datePublishedReg 2019-12-01
    65 schema:description BACKGROUND: Triple-negative breast cancers (TNBCs), which lack receptors for estrogen, progesterone, and amplification of epidermal growth factor receptor 2, are highly aggressive. Consequently, patients diagnosed with TNBCs have reduced overall and disease-free survival rates compared to patients with other subtypes of breast cancer. TNBCs are characterized by the presence of cancer cells with mesenchymal properties, indicating that the epithelial to mesenchymal transition (EMT) plays a major role in the progression of this disease. The EMT program has also been implicated in chemoresistance, tumor recurrence, and induction of cancer stem cell (CSC) properties. Currently, there are no targeted therapies for TNBC, and hence, it is critical to identify the novel targets to treat TNBC. METHODS: A library of compounds was screened for their ability to inhibit EMT in cells with mesenchymal phenotype as assessed using the previously described Z-cad reporters. Of the several drugs tested, GSK3β inhibitors were identified as EMT inhibitors. The effects of GSK3β inhibitors on the properties of TNBC cells with a mesenchymal phenotype were assessed using qRT-PCR, flow cytometry, western blot, mammosphere, and migration and cell viability assays. Publicly available datasets also were analyzed to examine if the expression of GSK3β correlates with the overall survival of breast cancer patients. RESULTS: We identified a GSK3β inhibitor, BIO, in a drug screen as one of the most potent inhibitors of EMT. BIO and two other GSK3β inhibitors, TWS119 and LiCl, also decreased the expression of mesenchymal markers in several different cell lines with a mesenchymal phenotype. Further, inhibition of GSK3β reduced EMT-related migratory properties of cells with mesenchymal properties. To determine if GSK3β inhibitors target mesenchymal-like cells by affecting the CSC population, we employed mammosphere assays and profiled the stem cell-related cell surface marker CD44+/24- in cells after exposure to GSK3β inhibitors. We found that GSK3β inhibitors indeed decreased the CSC properties of cell types with mesenchymal properties. We treated cells with epithelial and mesenchymal properties with GSK3β inhibitors and found that GSK3β inhibitors selectively kill cells with mesenchymal attributes while sparing cells with epithelial properties. We analyzed patient data to identify genes predictive of poor clinical outcome that could serve as novel therapeutic targets for TNBC. The Wnt signaling pathway is critical to EMT, but among the various factors known to be involved in Wnt signaling, only the higher expression of GSK3β correlated with poorer overall patient survival. CONCLUSIONS: Taken together, our data demonstrate that GSK3β is a potential target for TNBCs and suggest that GSK3β inhibitors could serve as selective inhibitors of EMT and CSC properties for the treatment of a subset of aggressive TNBC. GSK3β inhibitors should be tested for use in combination with standard-of-care drugs in preclinical TNBC models.
    66 schema:genre research_article
    67 schema:inLanguage en
    68 schema:isAccessibleForFree true
    69 schema:isPartOf N3e4c249c2d514a1f8463b141c70eb94c
    70 Neae0a12223fc4e7892a067529f8a1727
    71 sg:journal.1022375
    72 schema:name GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer
    73 schema:pagination 37
    74 schema:productId N2ef1989697cd42a28a19dc2f3f87bd71
    75 N3fb7a74b82f542d68ddfc883a540e81e
    76 N50f43f01f7e74ceeb07e0c2a29132c66
    77 Ndeae6723b76540c1b3313ae8598f6340
    78 Nea1083113925481181dc23d16bab5606
    79 schema:sameAs https://app.dimensions.ai/details/publication/pub.1112606607
    80 https://doi.org/10.1186/s13058-019-1125-0
    81 schema:sdDatePublished 2019-04-11T13:18
    82 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    83 schema:sdPublisher N571b027e1b4842c4a9b1712eb8b82b52
    84 schema:url https://link.springer.com/10.1186%2Fs13058-019-1125-0
    85 sgo:license sg:explorer/license/
    86 sgo:sdDataset articles
    87 rdf:type schema:ScholarlyArticle
    88 N021c5720722548b3a78ac56903d20986 schema:affiliation https://www.grid.ac/institutes/grid.240145.6
    89 schema:familyName Mani
    90 schema:givenName Sendurai A.
    91 rdf:type schema:Person
    92 N048211b1ebe342bea8d816ee6b1dd9bb schema:affiliation https://www.grid.ac/institutes/grid.240145.6
    93 schema:familyName Werden
    94 schema:givenName Steven J.
    95 rdf:type schema:Person
    96 N04dc533220794444b509dda41a427ed6 rdf:first Nc5b9493ad3844a22a31793720d3c712e
    97 rdf:rest N62ee71dca2fc411097fae420f3a7bf52
    98 N0c28a49be0db4fc19a5a40b4cd3143cb schema:affiliation https://www.grid.ac/institutes/grid.240145.6
    99 schema:familyName Joseph
    100 schema:givenName Robiya
    101 rdf:type schema:Person
    102 N0d5e23b7577c4135bd6557d37e43885e schema:affiliation https://www.grid.ac/institutes/grid.264756.4
    103 schema:familyName Sarkar
    104 schema:givenName Tapasree R.
    105 rdf:type schema:Person
    106 N0ece303414f0406abfc3000e1382dadc schema:affiliation https://www.grid.ac/institutes/grid.39382.33
    107 schema:familyName Zhao
    108 schema:givenName Na
    109 rdf:type schema:Person
    110 N0ff384a420ae47bbb9a215ae238b01c6 rdf:first Nae41da03c34e4293929d6e83607418d2
    111 rdf:rest N5bd101b56fbc472fbaf4bc5d3c94f1f1
    112 N15b15b042aa04c6ea86b18bee26af6a7 rdf:first N64969c91fad34d6aa96dd2b3044b7622
    113 rdf:rest Na71985a1af6544b9b4985959a4436336
    114 N16fe7461361c4e579d6f37d133fb06bd schema:affiliation https://www.grid.ac/institutes/grid.39382.33
    115 schema:familyName Toneff
    116 schema:givenName Mike J.
    117 rdf:type schema:Person
    118 N2ef1989697cd42a28a19dc2f3f87bd71 schema:name doi
    119 schema:value 10.1186/s13058-019-1125-0
    120 rdf:type schema:PropertyValue
    121 N359ba5c0504f495885942e90ab803526 schema:affiliation https://www.grid.ac/institutes/grid.240145.6
    122 schema:familyName Ramirez-Pena
    123 schema:givenName Esmeralda
    124 rdf:type schema:Person
    125 N3e4c249c2d514a1f8463b141c70eb94c schema:issueNumber 1
    126 rdf:type schema:PublicationIssue
    127 N3fb7a74b82f542d68ddfc883a540e81e schema:name readcube_id
    128 schema:value 3fb8ac3db2bd9e381a085b8b5ae3fd9559b8b751acdb5503513ebcc8a70a1df1
    129 rdf:type schema:PropertyValue
    130 N43f3fa4814734b9795b3118e95babdee rdf:first N359ba5c0504f495885942e90ab803526
    131 rdf:rest Naf75f04383bd4fc29f3314075fd25e3d
    132 N499b6df3884c46bbbc28a0e1b8d8d188 schema:affiliation https://www.grid.ac/institutes/grid.1374.1
    133 schema:familyName Pietila
    134 schema:givenName Mika
    135 rdf:type schema:Person
    136 N50f43f01f7e74ceeb07e0c2a29132c66 schema:name nlm_unique_id
    137 schema:value 100927353
    138 rdf:type schema:PropertyValue
    139 N571b027e1b4842c4a9b1712eb8b82b52 schema:name Springer Nature - SN SciGraph project
    140 rdf:type schema:Organization
    141 N5bd101b56fbc472fbaf4bc5d3c94f1f1 rdf:first N0d5e23b7577c4135bd6557d37e43885e
    142 rdf:rest N43f3fa4814734b9795b3118e95babdee
    143 N608a60b3321040f6967675860cdfa2b9 rdf:first N0c28a49be0db4fc19a5a40b4cd3143cb
    144 rdf:rest N9d599eb1094e4839a2da0de43c1c7e12
    145 N6222a763708741deb6f8d889981b6761 rdf:first Nba7e66ccd55f46c1ae1e6aeb98411df6
    146 rdf:rest Ncc401cce5dd140bc9bb3a10bdc49de43
    147 N62ee71dca2fc411097fae420f3a7bf52 rdf:first N0ece303414f0406abfc3000e1382dadc
    148 rdf:rest Nc92f5a5644014a13ae60b3413b72b72e
    149 N64969c91fad34d6aa96dd2b3044b7622 schema:affiliation https://www.grid.ac/institutes/grid.411951.9
    150 schema:familyName Miura
    151 schema:givenName Noayuki
    152 rdf:type schema:Person
    153 N678a89041d414b15a672d59e12d00786 rdf:first N16fe7461361c4e579d6f37d133fb06bd
    154 rdf:rest N608a60b3321040f6967675860cdfa2b9
    155 N7a89f12fb43f40379e5f012ff182abad rdf:first N021c5720722548b3a78ac56903d20986
    156 rdf:rest rdf:nil
    157 N7b78300e3b4e443ebd55a168f8d5d334 rdf:first Ndc2723314af24816900ca45f00ac760c
    158 rdf:rest Na21f607b83b64c78807e55a9b0dbabe1
    159 N83487bc0fb5e40188583b7d441b505df rdf:first N8ce2cf74479a41409c40e995dac2948a
    160 rdf:rest Nbd721fbd5add498e93eb1eafc319137b
    161 N8ce2cf74479a41409c40e995dac2948a schema:affiliation https://www.grid.ac/institutes/grid.418866.5
    162 schema:familyName Sobieski
    163 schema:givenName Mary
    164 rdf:type schema:Person
    165 N98c7fb2b760e419f91fa3b141f8b5963 schema:affiliation https://www.grid.ac/institutes/grid.39382.33
    166 schema:familyName Rosen
    167 schema:givenName Jeffrey M.
    168 rdf:type schema:Person
    169 N9d599eb1094e4839a2da0de43c1c7e12 rdf:first N499b6df3884c46bbbc28a0e1b8d8d188
    170 rdf:rest N0ff384a420ae47bbb9a215ae238b01c6
    171 Na21f607b83b64c78807e55a9b0dbabe1 rdf:first Ne06f11452cef4d91bbc068fd7dee17a6
    172 rdf:rest N83487bc0fb5e40188583b7d441b505df
    173 Na71985a1af6544b9b4985959a4436336 rdf:first Ncb62276c4abb497298ddefe9546ef9eb
    174 rdf:rest N6222a763708741deb6f8d889981b6761
    175 Nae41da03c34e4293929d6e83607418d2 schema:affiliation https://www.grid.ac/institutes/grid.252890.4
    176 schema:familyName Taube
    177 schema:givenName Joseph H.
    178 rdf:type schema:Person
    179 Naf75f04383bd4fc29f3314075fd25e3d rdf:first N048211b1ebe342bea8d816ee6b1dd9bb
    180 rdf:rest N7b78300e3b4e443ebd55a168f8d5d334
    181 Nb8cb185516fe4240aa6bce14e084cda4 rdf:first N98c7fb2b760e419f91fa3b141f8b5963
    182 rdf:rest N7a89f12fb43f40379e5f012ff182abad
    183 Nba7e66ccd55f46c1ae1e6aeb98411df6 schema:affiliation https://www.grid.ac/institutes/grid.267308.8
    184 schema:familyName Chang
    185 schema:givenName Jeffrey T.
    186 rdf:type schema:Person
    187 Nbd721fbd5add498e93eb1eafc319137b rdf:first Ned8cb85080df492db39406665aa1df9d
    188 rdf:rest Nebc51954129042e8a0915f1f6e660014
    189 Nc5b9493ad3844a22a31793720d3c712e schema:affiliation https://www.grid.ac/institutes/grid.240145.6
    190 schema:familyName Vijay
    191 schema:givenName Geraldine Vidhya
    192 rdf:type schema:Person
    193 Nc92f5a5644014a13ae60b3413b72b72e rdf:first Nf682f064f8ee423e8b90151b35a9f2d9
    194 rdf:rest N678a89041d414b15a672d59e12d00786
    195 Ncb62276c4abb497298ddefe9546ef9eb schema:affiliation https://www.grid.ac/institutes/grid.418866.5
    196 schema:familyName Davies
    197 schema:givenName Peter
    198 rdf:type schema:Person
    199 Ncc401cce5dd140bc9bb3a10bdc49de43 rdf:first Nfdb2f3559d8d4a8fbf4deae190144dab
    200 rdf:rest Nb8cb185516fe4240aa6bce14e084cda4
    201 Ndc2723314af24816900ca45f00ac760c schema:affiliation https://www.grid.ac/institutes/grid.240145.6
    202 schema:familyName Shariati
    203 schema:givenName Maryam
    204 rdf:type schema:Person
    205 Ndeae6723b76540c1b3313ae8598f6340 schema:name dimensions_id
    206 schema:value pub.1112606607
    207 rdf:type schema:PropertyValue
    208 Ne06f11452cef4d91bbc068fd7dee17a6 schema:affiliation https://www.grid.ac/institutes/grid.240145.6
    209 schema:familyName Gao
    210 schema:givenName Ruli
    211 rdf:type schema:Person
    212 Nea1083113925481181dc23d16bab5606 schema:name pubmed_id
    213 schema:value 30845991
    214 rdf:type schema:PropertyValue
    215 Neae0a12223fc4e7892a067529f8a1727 schema:volumeNumber 21
    216 rdf:type schema:PublicationVolume
    217 Nebc51954129042e8a0915f1f6e660014 rdf:first Nf6fd085d06a143eb83ebaa2a67bc95cf
    218 rdf:rest N15b15b042aa04c6ea86b18bee26af6a7
    219 Ned8cb85080df492db39406665aa1df9d schema:affiliation https://www.grid.ac/institutes/grid.418866.5
    220 schema:familyName Stephan
    221 schema:givenName Clifford C.
    222 rdf:type schema:Person
    223 Nf682f064f8ee423e8b90151b35a9f2d9 schema:affiliation https://www.grid.ac/institutes/grid.240145.6
    224 schema:familyName Den Hollander
    225 schema:givenName Petra
    226 rdf:type schema:Person
    227 Nf6fd085d06a143eb83ebaa2a67bc95cf schema:affiliation https://www.grid.ac/institutes/grid.240145.6
    228 schema:familyName Sphyris
    229 schema:givenName Nathalie
    230 rdf:type schema:Person
    231 Nfdb2f3559d8d4a8fbf4deae190144dab schema:affiliation https://www.grid.ac/institutes/grid.240145.6
    232 schema:familyName Soundararajan
    233 schema:givenName Rama
    234 rdf:type schema:Person
    235 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    236 schema:name Medical and Health Sciences
    237 rdf:type schema:DefinedTerm
    238 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
    239 schema:name Oncology and Carcinogenesis
    240 rdf:type schema:DefinedTerm
    241 sg:grant.2481213 http://pending.schema.org/fundedItem sg:pub.10.1186/s13058-019-1125-0
    242 rdf:type schema:MonetaryGrant
    243 sg:grant.5126625 http://pending.schema.org/fundedItem sg:pub.10.1186/s13058-019-1125-0
    244 rdf:type schema:MonetaryGrant
    245 sg:grant.7051495 http://pending.schema.org/fundedItem sg:pub.10.1186/s13058-019-1125-0
    246 rdf:type schema:MonetaryGrant
    247 sg:grant.7051777 http://pending.schema.org/fundedItem sg:pub.10.1186/s13058-019-1125-0
    248 rdf:type schema:MonetaryGrant
    249 sg:journal.1022375 schema:issn 1465-5411
    250 1465-542X
    251 schema:name Breast Cancer Research
    252 rdf:type schema:Periodical
    253 sg:pub.10.1007/s10549-012-2229-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044204802
    254 https://doi.org/10.1007/s10549-012-2229-8
    255 rdf:type schema:CreativeWork
    256 sg:pub.10.1007/s10549-012-2315-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1050772229
    257 https://doi.org/10.1007/s10549-012-2315-y
    258 rdf:type schema:CreativeWork
    259 sg:pub.10.1007/s11064-006-9128-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043905982
    260 https://doi.org/10.1007/s11064-006-9128-5
    261 rdf:type schema:CreativeWork
    262 sg:pub.10.1038/cr.2008.323 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031139620
    263 https://doi.org/10.1038/cr.2008.323
    264 rdf:type schema:CreativeWork
    265 sg:pub.10.1038/nature11412 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024942368
    266 https://doi.org/10.1038/nature11412
    267 rdf:type schema:CreativeWork
    268 sg:pub.10.1038/nrclinonc.2015.61 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050085746
    269 https://doi.org/10.1038/nrclinonc.2015.61
    270 rdf:type schema:CreativeWork
    271 sg:pub.10.1038/nrclinonc.2016.66 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011587927
    272 https://doi.org/10.1038/nrclinonc.2016.66
    273 rdf:type schema:CreativeWork
    274 sg:pub.10.1038/nrclinonc.2017.44 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084764660
    275 https://doi.org/10.1038/nrclinonc.2017.44
    276 rdf:type schema:CreativeWork
    277 sg:pub.10.1038/nrd1415 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051744913
    278 https://doi.org/10.1038/nrd1415
    279 rdf:type schema:CreativeWork
    280 sg:pub.10.1038/nrm3758 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000491787
    281 https://doi.org/10.1038/nrm3758
    282 rdf:type schema:CreativeWork
    283 sg:pub.10.1038/onc.2013.411 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001049720
    284 https://doi.org/10.1038/onc.2013.411
    285 rdf:type schema:CreativeWork
    286 sg:pub.10.1038/onc.2014.245 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043471529
    287 https://doi.org/10.1038/onc.2014.245
    288 rdf:type schema:CreativeWork
    289 sg:pub.10.1038/oncsis.2015.35 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053596349
    290 https://doi.org/10.1038/oncsis.2015.35
    291 rdf:type schema:CreativeWork
    292 sg:pub.10.1038/oncsis.2017.14 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084508969
    293 https://doi.org/10.1038/oncsis.2017.14
    294 rdf:type schema:CreativeWork
    295 sg:pub.10.1038/srep12465 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031306920
    296 https://doi.org/10.1038/srep12465
    297 rdf:type schema:CreativeWork
    298 sg:pub.10.1186/2001-1326-2-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029680491
    299 https://doi.org/10.1186/2001-1326-2-3
    300 rdf:type schema:CreativeWork
    301 sg:pub.10.1186/bcr3192 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046823214
    302 https://doi.org/10.1186/bcr3192
    303 rdf:type schema:CreativeWork
    304 sg:pub.10.1186/bcr3658 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043424385
    305 https://doi.org/10.1186/bcr3658
    306 rdf:type schema:CreativeWork
    307 sg:pub.10.1186/s12915-016-0269-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1015110461
    308 https://doi.org/10.1186/s12915-016-0269-y
    309 rdf:type schema:CreativeWork
    310 https://doi.org/10.1002/0471141755.ph1425s61 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053049974
    311 rdf:type schema:CreativeWork
    312 https://doi.org/10.1006/bbrc.2000.4169 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026928841
    313 rdf:type schema:CreativeWork
    314 https://doi.org/10.1016/j.ccr.2004.05.015 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048372678
    315 rdf:type schema:CreativeWork
    316 https://doi.org/10.1016/j.ccr.2006.01.013 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000216868
    317 rdf:type schema:CreativeWork
    318 https://doi.org/10.1016/j.cell.2006.10.018 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041684641
    319 rdf:type schema:CreativeWork
    320 https://doi.org/10.1016/j.cell.2008.03.027 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042567148
    321 rdf:type schema:CreativeWork
    322 https://doi.org/10.1016/j.cell.2010.11.034 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043690423
    323 rdf:type schema:CreativeWork
    324 https://doi.org/10.1016/j.chembiol.2003.11.010 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001271766
    325 rdf:type schema:CreativeWork
    326 https://doi.org/10.1016/j.pharmthera.2014.11.016 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011065299
    327 rdf:type schema:CreativeWork
    328 https://doi.org/10.1016/j.tibs.2009.10.002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038223348
    329 rdf:type schema:CreativeWork
    330 https://doi.org/10.1016/s1097-2765(01)00253-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000142222
    331 rdf:type schema:CreativeWork
    332 https://doi.org/10.1016/s1476-5586(04)80047-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019351767
    333 rdf:type schema:CreativeWork
    334 https://doi.org/10.1021/cn5000309 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053802760
    335 rdf:type schema:CreativeWork
    336 https://doi.org/10.1073/pnas.0703900104 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007846183
    337 rdf:type schema:CreativeWork
    338 https://doi.org/10.1073/pnas.0732087100 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052919657
    339 rdf:type schema:CreativeWork
    340 https://doi.org/10.1073/pnas.1004900107 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003168562
    341 rdf:type schema:CreativeWork
    342 https://doi.org/10.1093/abbs/gmv130 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026347802
    343 rdf:type schema:CreativeWork
    344 https://doi.org/10.1111/bdi.12361 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010874330
    345 rdf:type schema:CreativeWork
    346 https://doi.org/10.1111/j.1440-169x.2009.01141.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1023177784
    347 rdf:type schema:CreativeWork
    348 https://doi.org/10.1155/2017/2925869 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084229182
    349 rdf:type schema:CreativeWork
    350 https://doi.org/10.1158/0008-5472.can-06-3895 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015133922
    351 rdf:type schema:CreativeWork
    352 https://doi.org/10.1158/0008-5472.can-09-3360 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019637270
    353 rdf:type schema:CreativeWork
    354 https://doi.org/10.1158/0008-5472.can-12-2962 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041219104
    355 rdf:type schema:CreativeWork
    356 https://doi.org/10.1158/1078-0432.ccr-14-2820 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002537319
    357 rdf:type schema:CreativeWork
    358 https://doi.org/10.1158/1535-7163.mct-14-0778 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002334728
    359 rdf:type schema:CreativeWork
    360 https://doi.org/10.1172/jci39104 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026879393
    361 rdf:type schema:CreativeWork
    362 https://doi.org/10.1172/jci45014 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037799511
    363 rdf:type schema:CreativeWork
    364 https://doi.org/10.1177/2045125312471963 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043851180
    365 rdf:type schema:CreativeWork
    366 https://doi.org/10.1192/bjp.bp.116.181362 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064192192
    367 rdf:type schema:CreativeWork
    368 https://doi.org/10.1242/dev.066209 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046726359
    369 rdf:type schema:CreativeWork
    370 https://doi.org/10.18632/oncotarget.10337 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034068484
    371 rdf:type schema:CreativeWork
    372 https://doi.org/10.18632/oncotarget.11875 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048063128
    373 rdf:type schema:CreativeWork
    374 https://doi.org/10.18632/oncotarget.2037 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039354139
    375 rdf:type schema:CreativeWork
    376 https://doi.org/10.2147/ott.s91863 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001513144
    377 rdf:type schema:CreativeWork
    378 https://doi.org/10.3109/03008207.2015.1066780 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049695200
    379 rdf:type schema:CreativeWork
    380 https://doi.org/10.3389/fnmol.2012.00014 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051112334
    381 rdf:type schema:CreativeWork
    382 https://doi.org/10.3390/cancers5041545 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030381029
    383 rdf:type schema:CreativeWork
    384 https://doi.org/10.3390/cancers8070060 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028941023
    385 rdf:type schema:CreativeWork
    386 https://doi.org/10.3390/jcm5020013 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009522152
    387 rdf:type schema:CreativeWork
    388 https://doi.org/10.4161/19336918.2014.972761 schema:sameAs https://app.dimensions.ai/details/publication/pub.1072288597
    389 rdf:type schema:CreativeWork
    390 https://www.grid.ac/institutes/grid.1374.1 schema:alternateName University of Turku
    391 schema:name Turku Centre for Biotechnology, University of Turku, Tykistökatu 6, 20520, Turku, Finland
    392 rdf:type schema:Organization
    393 https://www.grid.ac/institutes/grid.240145.6 schema:alternateName The University of Texas MD Anderson Cancer Center
    394 schema:name Department of Genetics, The University of Texas MD Anderson Cancer Center, 77030, Houston, TX, USA
    395 Department of Translational Molecular Pathology, UT MD Anderson Cancer Center, Houston, TX, USA
    396 Metastasis Research Center, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    397 rdf:type schema:Organization
    398 https://www.grid.ac/institutes/grid.252890.4 schema:alternateName Baylor University
    399 schema:name Department of Biology, Baylor University, Waco, TX, USA
    400 rdf:type schema:Organization
    401 https://www.grid.ac/institutes/grid.264756.4 schema:alternateName Texas A&M University
    402 schema:name Center for Statistical Bioinformatics, Texas A&M University, College Station, TX, USA
    403 rdf:type schema:Organization
    404 https://www.grid.ac/institutes/grid.267308.8 schema:alternateName The University of Texas Health Science Center at Houston
    405 schema:name Center for Clinical and Translational Sciences, The University of Texas Health Science Center at Houston, Houston, TX, USA
    406 Department of Integrative Biology and Pharmacology, School of Medicine, School of Biomedical Informatics, UT Health Sciences Center at Houston, Houston, TX, USA
    407 rdf:type schema:Organization
    408 https://www.grid.ac/institutes/grid.39382.33 schema:alternateName Baylor College of Medicine
    409 schema:name Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA
    410 rdf:type schema:Organization
    411 https://www.grid.ac/institutes/grid.411951.9 schema:alternateName Hamamatsu University
    412 schema:name Department of Biochemistry, Hamamatsu University School of Medicine, Hamamatsu, Japan
    413 rdf:type schema:Organization
    414 https://www.grid.ac/institutes/grid.418866.5 schema:alternateName Texas A&M Health Science Center
    415 schema:name Center for Translational Cancer Research, Texas A&M Health Science Center, Institute of Biosciences and Technology, Houston, TX, USA
    416 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...